Introduction

Methods
Study Population
The Atherosclerosis Risk in Communities (ARIC) study is a multi-center population-based prospective study of risk factors for atherosclerosis and the burden of cardiovascular disease. apart (the last ending in 1998). In addition, participants received annual follow-up calls since the first visit inquiring about their health and hospitalizations. Details of the ARIC study design have been published 14 . The ARIC study was approved by institutional review boards at each participating center, and written informed consent was obtained from all participants.
In the present study, we excluded the participants who met any of the following hierarchical criteria based on the baseline study visit: a) missing or non-readable ECGs (n=85), or unknown prevalent AF status (n=225); b) prevalent AF or atrial flutter (n=37); c) missing (n=104) or implausible (n=12) data on lung function value; d) race/ethnicity other than African Americans or Caucasians (n=47); e) missing information on important covariates, including sitting height (n=15), cigarette smoke status (n=14), and cigarette-years of smoking (n=249).
After these exclusions, a total of 15,004 of participants (95% of original study cohort) remained for analysis.
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Electrocardiograms (ECGs) and a 2 two-minute rhythm strip from the first visit were examined to identify participants with prevalent AF or atrial flutter. Details for the assessment of AF have been reported previously 15 . AF events were identified from: 1) ECGs performed during followup exams; 2) death certificates (ICD-9 code 437.3 or ICD-10 code I48) 16 ; 3)hospital discharge records or death certificates through the end of follow up through 2008.
Hospitalizations in ARIC participants were identified through annual follow-up calls and review of local hospital discharges through 2008 17 . An AF diagnosis was assigned if AF was listed as any cause of death (ICD-9 427.3 or ICD-10 148). AF events identified during hospitalization for cardiac surgery were excluded as these may not relate to the natural history of AF and persistent will be capture in subsequent hospitalization. The validity of hospital discharge diagnoses for AF reported 84% sensitivity and 98% specificity in the ascertainment of AF event among ARIC cohort 15 . The date of incident AF was defined as the first date when ECGs showed AF, hospital discharge coded as AF or death date when AF was listed as a cause of death, whichever occurred first. Most AF incidence cases (87.4%) were identified through hospital discharge codes only. Supplemental Table 1 shows the distribution of AF cases according to the different sources of endpoint ascertainment.
Assessment of Pulmonary Function
The main measures of lung function were FEV 1 , the volume of gas exhaled in the first second of expiration; and forced vital capacity (FVC), the average maximal volume of gas exhaled after maximal inspiratory effort. Spirometry was conducted at baseline using a water-sealed Collins Survey II volume displacement spirometer (Collins Medical, Inc.) and Pulmo-Screen II software (PDS Healthcare Products, 496 Inc.). At least three acceptable spirograms were obtained from a minimum of five forced expirations. The best single spirograms was identified by a computer AF and persistent will be capture in subsequent hospitalization. The validity of ho ho osp p pit ital al al discharge diagnoses for AF reported 84% sensitivity and 98% specificity in the ascertainment of AF AF e e eve ve ve t nt nt a a amo mo mong g g A A ARI R C cohort 15 . The date of inci ci cide den nt AF was defi fi fine n d d as as as t the first date when and confirmed by a technician. Quality control was carefully conducted throughout the study 18 .
All procedures followed the American Thoracic Society guidelines 19 .
Assessment of respiratory symptoms was based on self-responses to a standardized questionnaire adapted from the Epidemiology Standardization Project 20 . Airflow obstruction was defined through two means either, a). Self-report of a physician diagnosis of emphysema, bronchitis, or asthma, or b). Spirometry. Post-bronchodilator measurements are required to define COPD optimally, but only pre-bronchodilator measurements were available in this study. 
Assessment of Covariates
For the present analysis, we used covariates measured at the first field center visit (1987-89).Anthropometric measures were obtained by trained, certified study personnel following a standardized protocol. Interviewers collected information on age, ethnicity, gender, smoking, highest education level, medical history, and other factors. For smoking history, participants identified themselves as current, former or never smokers. The average number of cigarette per day and number of years of smoking reported were multiplied to derive cigarette-years of smoking. Education level was classified as did not complete high school ( 11 years), high school diploma (12years), and at least some college (>12 years). Body mass index (BMI) was calculated from measurements of weight to the nearest pound and height to the nearest centimeter, with the participants standing in a scrub suit and without shoes. Sitting height was measured by having the participant sit on a stool approximately 32 inches high in a standard plus severe (FEV 1 < 80% of predicted value) per Global Obstructive Lung Disea ase s se ( ( (GO GO OLD LD LD) ) ) criteria 21 . Details of the airflow obstruction assessment in ARIC study have been published 22 .
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Participants were asked to bring their current medications at this visit. A medication use history was obtained by self-report of medication intake during last two weeks and by reviewing medication brought by participants to their visit. Each medication was coded by trained and certified interviewers with the use of a computerized medication classification system. Use of medications such as adrenergic beta-agonists, xanthine, and anti-cholinergics was examined as potential confounders. At baseline, inflammatory markers such as white cell count, hemostatic markers such as plasma fibrinogenprotein C, and von Willebrand factor, acute phase and nutrition marker such as albumin, and plasma lipid levels, were measured in central laboratories and using standardized and validated methods as previously described 23 . Prevalent CHD was defined as self-reported physician-diagnosed CHD or the presence of a previous myocardial infarction by ECGs, or self-reported history of coronary bypass or angioplasty of the coronary arteries. Prevalent HF was identified as presence of HF according to Gothenburg criteria 24 or self-reported HF medication use in the past 2 weeks.
Statistical Analysis
FEV1 and FVC vary widely by race and gender, and so does AF rates. Thus, all analyses used either race and gender specific FEV1 groupings or were done separately by race and gender.
Initially, we explored the association between measures of lung function and incident AF using restricted cubic spline (Figure 1 The following additional analyses were performed: a) stratified analyses by smoking status (never, former, and current) given its strong potential confounding effect, while adjusting for pack-years of smoking to reduce residual confounding in current or former smokers; b)
additional adjustment for obesity (BMI) and pro-inflammatory markers (including white blood cell count, fibrinogen level, albumin level, protein C, and von Willebrand factor) ; c) analyses after excluding those with (or missing information on) HF or CHD, and both to remove potential for confounding due to these conditions; d) analyses after excluding those without airflow obstruction to remove potential for ascertainment bias; and d) further adjustment for bronchodilators using (beta-agonist, xanthines, and anticholinergic). All analyses were conducted using SAS of version 9. those who remained AF free at the end of study follow up ( Table 2) .
Pulmonary function test and AF risk
The AF incidence rate decreased monotonically with higher FEV 1 quartiles in each of the four race-gender groups. The average incidence rates of AF per 1000 person years were inversely related to quartiles of FEV 1 and were (lowest to highest quartiles) 6.6, 3.8, 3.5 and 3.2 for white women; 13.7, 8.0, 7.8, and 6.2 for white men; 5.2, 3.2, 2.8, and 2.2 for black women; and 7.5, 5.2, 2.7 and 2.7 for black men, after adjusting for age and sitting height and height square ( Table 3) .
Similar patterns were observed for FVC quartiles (Supplemental Table 2 ). In analyses restricted to the never smokers group, significant inverse associations between lung function and incident AF were observed ( Table 4 ). The HRs comparing the lowest to highest quartiles of FEV 1 were of greater magnitude in African Americans (who had lower absolute rates) than among Caucasians (p for interaction = 0.15). These HRs were attenuated after additional adjustment for traditional CVD risk factors and systemic markers of inflammation but remained statistically significant. Independent of age, sitting height and smoking status, the hazards of incident AF hose who remained AF free at the end of study follow up ( t Table 2 ).
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comparison with previous studies we provide an analysis based on the continuous variable (Supplemental Table 5 ).
In sub-analyses, similar trend was observed for FVC quartiles; however, the inverse association was not significant after further adjusting for CVD risk factors and systemic markers of inflammation/hemostasis (Supplemental Table 2 ).
Since the associations between FEV 1 and FVC with incident AF appear to be approximately monotonic, models were fit using continuous lung function measures (Supplemental Table 5 ). Results are presented for 1 race-and gender-specific SD decreases.
The results were consistent with those from the quartile analyses. The cut points for quartile Table 2 ).
Airflow Obstruction and AF
In multivariable adjusted models, those with airflow obstruction (FEV 1 /FVC < 70%) had higher AF incidence than those without, hazard ratio were 1.58(1.29, 1.93) for white women, 1.37(1.17, association was not significant after further adjusting for CVD risk f f factors and s sy y yste te emi mi mic c ma ma mark rk rker e s k of inflammation/hemostasis (Supplemental Table 2 ). The results we we ere re e c c con on onsi si ist st ten nt t t wi wi w th h h t t tho ho hose s s f f fro ro rom m m th th he e e qu qu quar ar arti ti t le e e a a ana na naly ly lyse se ses. s. s T T Th h he e e cu cu cut t t po po p in in nts ts s f f for or oruartile 1.60) for white men, 1.10(0.73, 1.67) for black women, and 1.69(1.13, 2.55) for black men.
Si Si Sinc nc
Kaplan-Meier survival curves also suggested a monotonic association between airflow obstruction and incident AF (Figure 4) . Self-reported physician diagnosis of emphysema or asthma was associated with incident AF among black men but not among any other groups (Table 5) . Additional adjustment for use of beta adrenergic agonists, anti-cholinergics, and xanthines didn't change the effect estimates or their confidence interval for the association between FEV1 and AF, or between airflow obstruction and AF (data not shown).
Discussion
In this large population-based, bi-racial, bi-gender cohort, a lower FEV 1 was associated with a higher AF incidence independent of several confounders during an average follow up of 17.5
years. . This inverse association was independent of smoking: it persisted after adjustment for smoking status and cumulative amount smoked and was also seen among never smokers. We found four prospective population-based studies that also evaluated the association of lung function with the risk of AF [9] [10] [11] [12] . However, none of these above studies conducted a stratified analysis by smoking status. Our results are consistent with the short term follow up findings from both the Copenhagen City Heart Study 12 , and the Cardiovascular Health Study 10 . We extend these results with a longer follow up of a biracial cohort and establishing independence from smoking by examining never smokers separately.
We also observed an association of incident AF with both self-reported physician diagnosis of emphysema and spirometry-defined airflow obstruction. Our findings are consistent with a cross-sectional study 27 , where AF prevalence ratios increased with the severity of airflow obstruction.
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A few limitations in this study should be considered. Although AF ascertainment in our study was mostly based on hospital discharge codes, previous studies have shown that the validity of AF ascertainment using hospitalizations is acceptable 15, 44 , 
Conclusion
Our findings indicate that reduced lung function is associated with a higher incidence of AF, independent of race, gender, smoking, and several other CVD risk factors. Since AF may cause high morbidity from stroke and is associated with increased mortality, our findings suggest that more attention to AF in individuals with impaired lung function and airflow obstruction is warranted. If these findings are replicated in other cohorts, future studies of the potential mechanisms underlying the observed association may provide other opportunities for AF prevention.
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